FGF19-FGFR4 pathway has dual roles in liver health and cancer
A review published in Genes & Diseases examines a pathway that can both protect the liver and contribute to its destruction. Researchers at Tongji Hospital, Huazhong University of Science and Technology, describe how FGF19-FGFR4 signalling regulates metabolism and tissue repair, while abnormal activation can promote liver cancer and complicate treatment.
Read original article on The Medical News →